Oncology Insights

A Catalyst Oncology Newsletter

Welcome to the launch of our monthly Catalyst Oncology Newsletter! Each month we will be sharing upcoming events and news in our world of oncology clinical trials. This month is a special one as we announce the new leader of Catalyst Oncology: Keya Watkins!?

Keya brings 25 years of experience in drug development with both biopharma and clinical service providers. As Senior Vice President of Catalyst Oncology, Keya is responsible for the execution of the Oncology CRO Operations. Keya has built and provided oversight of multidisciplinary teams across clinical development operations inclusive of clinical operations, data sciences and trial support services previously. She also served as an executive in both operational and commercial roles and has been involved in several complex, global trials in various therapeutic areas and phases with a concentration on oncology and hematology programs. Keya prides herself on building and managing high-functioning teams that deliver excellence while ultimately bringing meaningful therapies to patients in need. Keya earned her degree from Temple University, Philadelphia, Pennsylvania, and also maintains her certification as a Project Management Professional.?

We announced this great news on LinkedIn, so take a look at the post and share your thoughts! ?

Wondering what else is happening at Catalyst, we have lots of news and information, including our many exciting leadership changes happening at Catalyst!?

White paper: “Enhancing the Data Journey in Oncology Clinical Trials”?

Visit our website to access the “Enhancing the Data Journey in Oncology Clinical Trials” white paper. The connection between EHR and EDC creates an opportunity for innovative approaches using technology to better streamline trial processes, enhancing data accuracy, reducing cost, and expediting the development of new therapies. Learn more about how Catalyst Oncology does this.?

Upcoming!?

• Meet with us to discuss how our experience with immuno-oncology trials can help develop your asset! We have meetings available from 27-29 February in Brooklyn, NY, for IO360. Sign up today for a complimentary session! ?
• In April, our Catalyst Oncology team will be attending the Society for Nuclear Medical Professionals in New Zealand. We hope to see you there!?